Changmao Biochemical Engineering Company Limited (Changmao Bio) has announced that its board of directors will convene on 18 August 2026 at 3:00 p.m. in the People’s Republic of China.
The agenda includes: 1. Approval of the unaudited interim results for the six months ended 30 June 2026 and endorsement of the corresponding results announcement for publication on the Hong Kong Stock Exchange website. 2. Consideration of an interim dividend payout, if any. 3. Review of any necessary closure period for the Register of Members. 4. Discussion of other routine corporate matters.
The meeting notice was signed by Chairman Rui Xin Sheng on 3 August 2026. As of the announcement date, the board comprises three executive directors, three non-executive directors and three independent non-executive directors.